Thyroid — Class II drug recall D-0022-2019
Terminated recall by Humco Holding Group, Inc, reported 2018-10-24, distributed nationwide. CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the activ
| Recall number | D-0022-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Humco Holding Group, Inc, Texarkana, TX, United States |
| Recall initiated | 2018-08-28 |
| Classified | 2018-10-12 |
| Reported by FDA | 2018-10-24 |
| Terminated | 2020-05-07 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp |
| NDC | 00395-8077-43 |
| Lot numbers | A24542, A25528, A27119, A27810 |
| Expiration dates | 2019-02, 2019-04, 2019-05, 2019-06 |
Product
Thyroid, USP (Porcine) Levothyroxine 36.3 mcg/grain Liothyronine 9.7 mcg/grain Active Pharmaceutical Ingredient Rx Only 1000 grams NDC 0395-8077-43 Packaged by: Humco Texarkana, TX 75501
Reason for recall
CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0022-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.